As per MRFR analysis, the Cannabidiol (CBD) Market Size was estimated at 9.53 (USD Billion) in 2023. The Cannabidiol (CBD) Market Industry is expected to grow from 10.48(USD Billion) in 2024 to 30 (USD Billion) by 2035. The Cannabidiol (CBD) Market CAGR (growth rate) is expected to be around 10.03% during the forecast period (2025 - 2035).
The Global Cannabidiol (CBD) Market is currently experiencing substantial market trends that are being driven by the growing acceptance of Cannabidiol (CBD) for a variety of applications, particularly in the wellness and health sectors. A critical market driver is the increasing recognition of the potential advantages of Cannabidiol (CBD), including its analgesic, anti-inflammatory, and anxiolytic properties. This growing acceptance, in conjunction with the legal status of hemp-derived Cannabidiol (CBD) in numerous regions, has provided businesses with the opportunity to investigate and capitalize on new product formulations and applications. Opportunities are emerging in sectors such as cosmetics, dietary supplements, and food and beverages as a result of the growing consumer base's desire for natural alternatives to pharmaceutical products.
Additionally, the demand for Cannabidiol (CBD) products has increased significantly among younger demographics, particularly as lifestyles transition to health-oriented, natural remedies, as evidenced by recent trends. This demographic is actively searching out products that are consistent with their values regarding sustainability and ethical sourcing, which is influencing the market to prioritize transparency in sourcing and innovative product development. In addition, e-commerce platforms are becoming a popular and effective distribution channel, providing companies with the opportunity to directly engage with consumers and establish brand loyalty in the competitive global market. The surge is being driven by regions such as North America and Europe, which have supportive regulatory frameworks. However, other areas are beginning to recognize the potential economic benefits of embracing Cannabidiol (CBD) markets, which suggests a future shift in global trade dynamics.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Growing Acceptance of Cannabidiol (CBD) as a Wellness Product
The increasing acceptance of Cannabidiol (CBD) as a beneficial wellness product across the globe is a major driver for the Global Cannabidiol (CBD) Market Industry. Recent studies indicate that approximately 64% of U.S. adults are now aware of CBD and its potential therapeutic benefits, reflecting a significant cultural shift towards embracing natural alternatives for health and wellness. Organizations such as the World Health Organization (WHO) have emphasized the non-psychoactive nature of CBD and its potential to treat various conditions, including anxiety, epilepsy, and chronic pain.
The transparent canvas created by this regulatory recognition is encouraging manufacturers and investors to explore the CBD market further. In addition, with the global rise of health consciousness and preference for natural products, the demand for CBD-infused products is expanding rapidly, leading to growth potential projected over the coming years. This evolution is supported by the increased number of CBD brands entering the market and an upward trend in distribution channels such as e-commerce, indicating robust sales growth in the wellness segment.
Legislation and Regulatory Support
Changes in legislation and regulatory support for Cannabidiol (CBD) are imperative drivers for the Global Cannabidiol (CBD) Market Industry. Numerous countries are relaxing their regulations surrounding the use of hemp-derived CBD, paving the way for broader commercialization. In the United States, the passing of the 2018 Farm Bill legalized hemp cultivation, leading to a significant increase of over 300% in licensed hemp farms within two years, as reported by the U.S.
Department of Agriculture. This legislative framework significantly enhances the supply chain and distribution channels for CBD products, allowing for a robust engagement of businesses in this field. Countries leading the charge on CBD legislation, including Canada and Uruguay, are setting precedents for international markets, inspiring similar movements in Europe and Asia. With supportive policies gaining traction globally, new opportunities for product development and market entry are being realized.
Surge in Research and Development Activities
The surge in Research and Development (R&D) activities focusing on Cannabidiol (CBD) is significantly driving the Global Cannabidiol (CBD) Market Industry. A significant increase in clinical trials aimed at determining the efficacy of CBD for various medical conditions, such as Alzheimer’s disease and Parkinson’s disease, emphasizes the upward trend in research expenditure. The National Institutes of Health (NIH) has reported a 20% annual increase in funding for cannabis-based research projects, signaling robust governmental support and interest in exploring the medical benefits of CBD.
This funding underwrites the development of innovative formulations and product applications across pharmaceutical and nutraceutical sectors, which can benefit from the therapeutic properties attributed to CBD. As a result, businesses investing in innovative developments stand to gain competitive advantages and drive market growth significantly.
Increasing Interest in CBD in Personal Care Products
Another driver propelling the Global Cannabidiol (CBD) Market Industry is the increasing incorporation of Cannabidiol (CBD) into personal care and beauty products. Recent reports indicate that the global skincare market infused with CBD is projected to grow at an impressive rate, with a forecasted increase of 20% annually over the next decade, driven by growing consumer interest in natural and clean beauty products. Major brands like Estée Lauder and L'Oréal have introduced CBD-infused lines, reflecting a shift in consumer preferences towards products that offer both luxury and wellness attributes.
The ability of CBD to offer anti-inflammatory and antioxidant properties is enhancing its appeal in skincare formulations. Such trends aligned with growing awareness about CBD's potential in holistic beauty regimens are influencing both consumer purchasing behavior and manufacturer production strategies, solidifying the position of CBD within the personal care sector.
The Global Cannabidiol (CBD) Market is experiencing significant growth, particularly in the Application segment, which is expected to emerge as a crucial area over the coming years. By 2024, the Application segment alone is projected to contribute significantly to the overall market valuation of 10.48 USD Billion. Among the various categories within this segment, Food and Beverages is notable, with a value of 3.12 USD Billion in 2024, predicted to rise to 9.0 USD Billion by 2035. This represents a remarkable growth trajectory fueled by increasing consumer demand for natural ingredients in food products.
Health Products follows closely, projected to reach 2.65 USD Billion in 2024 and growing to 7.54 USD Billion by 2035, illustrating a shift toward incorporating Cannabidiol (CBD) for improved wellness and health benefits. The Cosmetics sub-segment, valued at 1.05 USD Billion in 2024, is expected to grow to 3.0 USD Billion by 2035, reflecting the rise in popularity of CBD-infused skincare products known for their therapeutic properties. Pharmaceuticals, comprising a critical area of the market, are forecasted to grow from 2.21 USD Billion in 2024 to 6.3 USD Billion by 2035, showcasing the sector's commitment to harnessing Cannabidiol (CBD)'s efficacy for numerous medical applications, especially as research continues to validate its therapeutic potential.
Finally, the Pet Care segment, valued at 1.45 USD Billion in 2024, is expected to rise to 4.16 USD Billion by 2035, highlighting the growing awareness and acceptance of Cannabidiol (CBD) as a beneficial supplement for pets. As consumers increasingly prioritize health and wellness, the various applications of Cannabidiol (CBD) across these segments present numerous opportunities for innovation and market penetration. With the Global Cannabidiol (CBD) Market segmentation reflecting diverse consumer interests, these areas are poised for robust growth, driven by shifting consumer behaviors and the increasing legalization of Cannabidiol (CBD) products across many regions worldwide.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
In the Global Cannabidiol (CBD) Market, the Extract Type segment plays a crucial role, contributing significantly to the market's overall growth and diversity. By 2024, the Global Cannabidiol (CBD) Market is projected to be valued at 10.48 billion USD, reflecting a strong demand for various extract types. Among these, Full Spectrum extracts are renowned for their comprehensive cannabinoid content, often chosen for their synergistic effects, which resonate well with consumers seeking holistic benefits. Broad Spectrum extracts, which maintain multiple cannabinoids while excluding THC, cater to a growing audience that desires the therapeutic potential of cannabinoids without psychoactive effects.
Meanwhile, Isolate remains significant as it offers pure Cannabidiol (CBD), appealing to consumers who prefer precise dosing and minimal additives. The ongoing trend toward natural and plant-based products, combined with increasing awareness regarding the health benefits of cannabinoids, drives the market growth. Additionally, evolving regulations and a shift in consumer attitudes toward wellness and alternative medications present new opportunities within the Global Cannabidiol (CBD) Market. As this sector continues to expand, precise segmentation through Extract Types helps in fulfilling varying consumer preferences and ensures tailored product offerings.
The Global Cannabidiol (CBD) Market is experiencing substantial growth within its Distribution Channel segment, which encompasses Online platforms, Retail Stores, and Pharmacies. In 2024, the market is expected to reach a valuation of 10.48 USD Billion, indicative of its expanding reach and acceptance. Online sales have gained significant traction due to increasing consumer preference for convenience and accessibility, contributing to the overall market growth. Retail Stores also play a crucial role, providing consumers with the ability to browse products physically and receive immediate assistance from staff.
Pharmacies, often seen as trusted sources, are integral for consumers seeking health-focused products, ensuring compliance with regulations. The interplay between these channels is shaping Global Cannabidiol (CBD) Market revenue, with each channel catering to specific consumer needs and preferences. Trends also suggest that digital marketing and e-commerce innovations will further strengthen Online presence while Retail Stores and Pharmacies continue to adapt to changing consumer behavior. The Global Cannabidiol (CBD) Market segmentation highlights diverse opportunities across these channels, driven by evolving market growth dynamics and consumer education on product benefits.
The Global Cannabidiol (CBD) Market encompasses a diverse range of forms, including oils, capsules, edibles, and topicals, which cater to varying consumer preferences and therapeutic needs. By 2024, the overall Global Cannabidiol (CBD) Market is expected to reach a valuation of 10.48 USD Billion, signaling strong demand across its various forms. Oils often lead in popularity due to their versatility and rapid absorption, appealing to users seeking immediate effects. Capsules are gaining traction for their convenience and precise dosing, positioning them as a significant choice for consumers preferring a more traditional method of administration.
Edibles, particularly in the form of gummies and beverages, have attracted a younger demographic, combining enjoyment with wellness. Topicals also hold a vital role, especially for users targeting localized discomfort, making them an essential segment in the market. The segment's robust growth is fueled by rising consumer awareness of the health benefits of Cannabidiol (CBD), regulatory changes supporting hemp-derived products, and increasing product availability. Meanwhile, challenges like regulatory uncertainties and market saturation remain, providing opportunities for innovation and strategic marketing within this dynamic segment of the Global Cannabidiol (CBD) Market.
The Regional segment of the Global Cannabidiol (CBD) Market showcases a diverse landscape with varying valuations and growth trajectories. In 2024, North America holds the majority, valued at 4.2 USD Billion, reflecting its significant demand and consumer interest, particularly in states where legalization has spurred product availability. Europe follows with a valuation of 2.7 USD Billion, demonstrating a growing acceptance for Cannabidiol (CBD) products, driven by expanding regulations and market entry strategies from international players. The APAC region, valued at 2.1 USD Billion in 2024, shows promise as consumer awareness increases, particularly among countries like Japan and South Korea that are beginning to embrace Cannabidiol (CBD) applications.
South America and the Middle East and Africa (MEA) are valued at 0.8 USD Billion and 0.68 USD Billion, respectively, which indicates emerging markets that present opportunities as regulatory frameworks evolve. As the Global Cannabidiol (CBD) Market seeks to expand, these regions offer unique growth drivers, with North America dominating due to its advanced infrastructure and research focusing on health and wellness trends, making it a pivotal player within the market.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Cannabidiol (CBD) Market Key Players and Competitive Insights:
The Global Cannabidiol (CBD) Market is witnessing significant growth driven by the increasing awareness of the therapeutic benefits of Cannabidiol (CBD) and its rising acceptance across various consumer sectors. This market is characterized by a diverse range of players, from established pharmaceutical companies to emerging start-ups, which are rapidly innovating and introducing new products to meet the evolving needs of consumers. The competitive landscape is shaped by factors such as product differentiation, pricing strategies, distribution channels, and branding efforts. Moreover, the ongoing regulatory changes and the push for research into the health benefits of CBD are likely to create both challenges and opportunities for companies operating in this space.
Freya stands out in the Global Cannabidiol (CBD) Market with a robust product portfolio that emphasizes quality and efficacy. The company has established a strong brand presence that resonates with consumers seeking natural and effective health solutions. Freya's strengths lie in its commitment to sustainable sourcing and the innovative use of technology in product development. By focusing on transparency and education, the company has cultivated a loyal customer base and positioned itself favorably within the competitive environment. Its rigorous quality control measures and adherence to regulatory standards reinforce its reputation, enabling Freya to leverage its strengths and expand its market share in the ever-evolving landscape of the global CBD market.
Khiron Life Sciences has made a strategic impact on the Global Cannabidiol (CBD) Market with its comprehensive product offerings that cater to both medical and wellness sectors. The company has developed a portfolio that includes CBD oils, edibles, and topical formulations, emphasizing high-quality sourcing and clinical efficacy. Khiron Life Sciences is recognized for its strong market presence across various countries, bolstered by partnerships and collaborations that enhance its distribution network. The company's focus on research and development has led to innovative product formulations that address consumer needs, positioning it as a leader in the global CBD landscape. Furthermore, through strategic mergers and acquisitions, Khiron Life Sciences has expanded its operational capabilities and market reach, solidifying its competitive edge in this dynamic industry.
Key Companies in the Cannabidiol (CBD) Market Include:
Cannabidiol (CBD) Market Industry Developments
Recent developments in the Global Cannabidiol (CBD) Market include notable advancements in regulatory frameworks and significant corporate activities. Companies like Tilray and Aphria have been active in expanding their portfolios, reflecting a rising demand for CBD products across various sectors, including wellness and food. As of October 2023, Freya and Charlotte's Web have strengthened their market presence through enhanced distribution networks and product innovations. Current affairs indicate a growing acceptance of CBD products, driven by increasing consumer awareness and changing legislative landscapes.
The market valuation of key players such as Green Thumb Industries and Canopy Growth has shown promising growth, attributed to strategic investments and partnerships focusing on Research and Development to tap into emerging markets. Additionally, recent merger activities, such as the acquisition of Veritas Farms by a private equity firm in September 2023, highlight a consolidation trend within the industry. Historically, the market has seen transformative changes, with GW Pharmaceuticals achieving a major milestone in June 2021 by receiving FDA approval for its cannabinoid-based medications, setting the stage for enhanced credibility and robustness in the Global Cannabidiol (CBD) landscape.
| Report Attribute/Metric | Details |
| Market Size 2023 | 9.53(USD Billion) |
| Market Size 2024 | 10.48(USD Billion) |
| Market Size 2035 | 30.0(USD Billion) |
| Compound Annual Growth Rate (CAGR) | 10.03% (2025 - 2035) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Base Year | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Billion |
| Key Companies Profiled | Freya, Khiron Life Sciences, Aphria, Harbor House Collective, Tilray, Charlotte's Web, Green Thumb Industries, CV Sciences, Hexo, Aurora Cannabis, GW Pharmaceuticals, Elixinol, Veritas Farms, Canopy Growth, Medterra |
| Segments Covered | Application, Extract Type, Distribution Channel, Form, Regional |
| Key Market Opportunities | Rising health and wellness trends, Increasing acceptance for medicinal use, Growth in pet products segment, Expansion of e-commerce sales, Innovations in product formulations |
| Key Market Dynamics | regulatory developments, increasing consumer demand, expanding application areas, rising acceptance of cannabis products, growing e-commerce channels |
| Countries Covered | North America, Europe, APAC, South America, MEA |
CBD Market Highlights:
Frequently Asked Questions (FAQ) :
The Global Cannabidiol (CBD) Market is expected to be valued at 10.48 USD Billion in 2024.
By 2035, the Global Cannabidiol (CBD) Market is projected to reach a value of 30.0 USD Billion.
The expected CAGR for the Global Cannabidiol (CBD) Market from 2025 to 2035 is 10.03 percent.
In 2024, North America is the largest market for Cannabidiol (CBD), valued at 4.2 USD Billion.
The estimated market size for Cannabidiol (CBD) in Europe in 2024 is 2.7 USD Billion.
The Food Beverages segment of the Global Cannabidiol (CBD) Market is expected to reach 9.0 USD Billion by 2035.
Major players in the Global Cannabidiol (CBD) Market include Freya, Khiron Life Sciences, and Charlotte's Web.
The Pharmaceuticals segment for Cannabidiol (CBD) is expected to be valued at 6.3 USD Billion by 2035.
The anticipated market size for Cannabidiol (CBD) in the APAC region is expected to reach 6.0 USD Billion by 2035.
The Cosmetics segment of the Cannabidiol (CBD) Market is expected to grow to 3.0 USD Billion by 2035.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
| FEATURES | LICENCE TYPE | ||
|---|---|---|---|
| Single User | Multiuser Licence | Enterprise User | |
| Price | $ 4,950 | $ 5,950 | $ 7,250 |
| Maximum User Access Limit | 1 User | Upto 10 Users | Unrestricted Access Throughout The Organization. |
| Free Customization |  |
|
|
| Direct access to the Analyst | |
|
|
| Deliverable Format | |
|
|
 |
|
|
|
| Platform Access | |
|
|
| Discount on Your Next Purchase | 10% | 15% | 10% |
| Printable Versions | |
|
|
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
